NFKB1 and Insulin resistance: Briefly, TLR4 activation by either lipopolysaccharides or fatty acids leads to metabolic inflammation and insulin resistance via NF‐κB signaling axis, while estrogen deficiency or impaired estrogen signaling is associated with insulin resistance and dysregulation of metabolic homeostasis.